(Q52644149)

5 May 2018

title

SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients. (English)

1 reference

5 May 2018

1 reference

10

T Haferlach

1 reference

5 May 2018

3

C Haferlach

1 reference

5 May 2018

12

S Schnittger

1 reference

5 May 2018

author name string

S Jeromin

1

1 reference

5 May 2018

S Weissmann

2

1 reference

5 May 2018

F Dicker

4

1 reference

5 May 2018

K Bayer

5

1 reference

5 May 2018

V Grossmann

6

1 reference

5 May 2018

T Alpermann

7

1 reference

5 May 2018

A Roller

8

1 reference

5 May 2018

A Kohlmann

9

1 reference

5 May 2018

W Kern

11

1 reference

5 May 2018

publication date

12 September 2013

1 reference

5 May 2018

published in

Leukemia

1 reference

5 May 2018

volume

28

1 reference

5 May 2018

page(s)

108-117

1 reference

5 May 2018

issue

1

1 reference

5 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2013.263

exact match

0 references

cites work

Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

NOTCH1 mutations in CLL associated with trisomy 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Structural basis for leucine-rich nuclear export signal recognition by CRM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1,229 patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Diagnostic issues in chronic lymphocytic leukaemia (CLL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Genomic aberrations and survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Oncogenically active MYD88 mutations in human lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.263

The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

21 January 2018

1 reference

12 December 2020

Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping

1 reference

12 December 2020

Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients

1 reference

12 December 2020

Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression

1 reference

12 December 2020

Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

1 reference

12 December 2020

Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2013.263

1 reference

5 May 2018

PubMed ID

24113472

1 reference

5 May 2018